PURPOSE: To analyze 65 @entity1 with @entity2184 treated with @entity1953 plaque therapy with regards to mortality, visual results and complications. @entity1 AND METHODS: Most of the @entity320 were large (T3: 52.5%), with a mean largest dimension of the base of 11 mm, and a mean thickness of 6 mm. Most of the @entity5 were located in the choroid (95%), with an anterior margin behind the equator (65%), and a posterior margin at less than 3 mm of the disc and/or of the macula (69%). The plaque radiotherapy delivered a mean dose of 95 Gy to the @entity5 apex, either with a @entity1953 plaque alone (51 cases), or in association with a @entity3739 plaque (14 cases). The mean follow up period was over 8 years. RESULTS: The local control was achieved initially in 86% of the eyes. The estimated @entity320 specific survival rate was 83% after 5 years and 74% after 10 years. The main parameter associated with the metastases was the largest dimension of the base (p < 0.01). The eye was retained in 83% of the cases. The probability of keeping a vision better than or equal to 0,1 was 39% after 5 years and 27% after 10 years. The main parameter associated with the @entity227 was the @entity5 size (p < 0.01). The complications included @entity231 (39%), @entity989 (34%), with @entity1020 (19%) and/or papillopathy (13.5%), @entity548 (22%), @entity2297 (15%) and @entity1713 (12%). CONCLUSION: These results supported the value of @entity1953 plaque radiotherapy in the management of @entity2184 .

[Long-term results of XXXX 60 curietherapy for @entity2184 ].

@entity1 :: ('9606', 'Species') :: ['patients', 'PATIENTS'] @entity227 :: ('MESH:D014786', 'Disease') :: ['visual loss'] @entity231 :: ('MESH:D002386', 'Disease') :: ['cataract'] @entity548 :: ('MESH:D006470', 'Disease') :: ['vitreous hemorrhages'] @entity5 :: ('MESH:D009369', 'Disease') :: ['tumor', 'tumors'] @entity1713 :: ('MESH:D012163', 'Disease') :: ['retinal detachment'] @entity3739 :: ('MESH:D012428', 'Chemical') :: ['ruthenium'] @entity2184 :: ('MESH:C536494', 'Disease') :: ['uveal melanomas'] @entity989 :: ('MESH:D012164', 'Disease') :: ['radiation retinopathy'] @entity1020 :: ('MESH:D008268', 'Disease') :: ['maculopathy'] @entity1953 :: ('MESH:D003035', 'Chemical') :: ['cobalt'] @entity320 :: ('MESH:D008545', 'Disease') :: ['melanoma', 'melanomas'] @entity2297 :: ('MESH:D015355', 'Disease') :: ['neovascular glaucoma']
@entity1953 :: (MESH:D003035,Chemical) :: ['cobalt']
